Insider Selling: Teladoc Health, Inc. (NYSE:TDOC) Insider Sells 10,411 Shares of Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Laizer Kornwasser sold 10,411 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total transaction of $132,115.59. Following the transaction, the insider now directly owns 86,070 shares in the company, valued at $1,092,228.30. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Laizer Kornwasser also recently made the following trade(s):

• On Friday, February 2nd, Laizer Kornwasser sold 7,882 shares of Teladoc Health stock. The shares were sold at an average price of $19.18, for a total transaction of $151,176.76.

Teladoc Health Stock Performance

TDOC stock traded up $0.18 during trading on Thursday, hitting $13.00. 5,025,101 shares of the company’s stock traded hands, compared to its average volume of 4,835,000. The company has a quick ratio of 3.47, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. Teladoc Health, Inc. has a 52 week low of $12.53 and a 52 week high of $30.41. The stock has a fifty day moving average price of $14.48 and a two-hundred day moving average price of $17.60. The stock has a market capitalization of $2.20 billion, a price-to-earnings ratio of -9.08 and a beta of 0.97.

Teladoc Health (NYSE:TDOC) last released its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share for the quarter, missing the consensus estimate of ($0.47) by ($0.02). Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The business had revenue of $646.13 million for the quarter, compared to the consensus estimate of $637.31 million. During the same quarter in the previous year, the firm earned ($0.37) EPS. The firm’s revenue for the quarter was up 2.7% on a year-over-year basis. As a group, equities analysts anticipate that Teladoc Health, Inc. will post -1.04 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have weighed in on TDOC shares. Citigroup reduced their price target on shares of Teladoc Health from $21.00 to $19.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 21st. Leerink Partnrs reaffirmed a “market perform” rating on shares of Teladoc Health in a research report on Monday, February 26th. Wells Fargo & Company reduced their target price on shares of Teladoc Health from $17.00 to $15.00 and set an “equal weight” rating on the stock in a research report on Monday. Truist Financial reduced their target price on shares of Teladoc Health from $23.00 to $17.00 and set a “hold” rating on the stock in a research report on Wednesday, March 6th. Finally, TD Cowen reduced their target price on shares of Teladoc Health from $16.00 to $15.00 and set a “hold” rating on the stock in a research report on Friday, April 26th. Twelve analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Hold” and a consensus price target of $18.73.

Institutional Trading of Teladoc Health

Several institutional investors have recently added to or reduced their stakes in the business. Farrow Financial Inc. grew its position in shares of Teladoc Health by 17.3% during the first quarter. Farrow Financial Inc. now owns 91,591 shares of the health services provider’s stock worth $1,383,000 after acquiring an additional 13,521 shares during the last quarter. Capstone Investment Advisors LLC grew its position in shares of Teladoc Health by 44.8% during the first quarter. Capstone Investment Advisors LLC now owns 32,196 shares of the health services provider’s stock worth $486,000 after acquiring an additional 9,968 shares during the last quarter. Janney Montgomery Scott LLC grew its position in shares of Teladoc Health by 188.7% during the first quarter. Janney Montgomery Scott LLC now owns 31,594 shares of the health services provider’s stock worth $477,000 after acquiring an additional 20,651 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. grew its position in shares of Teladoc Health by 40.8% during the first quarter. Mirae Asset Global Investments Co. Ltd. now owns 209,689 shares of the health services provider’s stock worth $3,166,000 after acquiring an additional 60,780 shares during the last quarter. Finally, Allspring Global Investments Holdings LLC grew its position in shares of Teladoc Health by 74.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 20,568 shares of the health services provider’s stock worth $311,000 after acquiring an additional 8,750 shares during the last quarter. Institutional investors own 76.82% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.